Formulation: A liquid

Purity: ≥98%

• 5,5-Dimethyl-1-Pyrroline-N-Oxide

Formulation: A neat oil

Purity: ≥95%

• 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide

Formulation: A crystalline solid

Purity: ≥98%

• BocMPO

Formulation: A crystalline solid

Purity: ≥98%

• PBN

Formulation: A crystalline solid

Purity: ≥95%

• RR 071

Formulation: A 100 µg/ml solution in ethanol

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

• CPI-22
• Disufenton Sodium

Formulation: A 25 mg/ml solution in ethanol

Purity: ≥95%

• 5-(Ethoxycarbonyl)-5-methyl-1-Pyrroline-N-Oxide

Formulation: A crystalline solid

Purity: ≥95%

• 4-hydroxy TEMPO

Formulation: A crystalline solid

Purity: ≥98%

• α-Phenyltetramethylnitronyl nitroxide

Formulation: A crystalline solid

Purity: ≥98%

• 4-Carboxyl-2,2,6,6-tetramethylpiperidin-1-oxyl

Formulation: A crystalline solid

Purity: ≥98%

• 4-POBN

Formulation: A crystalline solid

Purity: ≥98%

• 4-oxo-TEMPO
• Triacetoneamine nitroxide

Formulation: A crystalline solid

Purity: ≥95%

• NSC 66479

Formulation: A solid

Purity: ≥98%

• M₄PO
• NSC 78027
• 3,3,5,5-Tetramethyl-1-pyrroline N-oxide

Formulation: A solid

Purity: ≥98%

• 2,2’-Pyridylisatogen tosylate